✦ LIBER ✦

PO55 THE COMBINATION CHEMOTHERAPY OF GEMCITABINE AND VINORELBINE IN HER2-NEGATIVE PATIENTS WITH TAXANE-PRETREATED METASTATIC BREAST CANCER: A PHASE II STUDY OF KINKI MULTIDISCIPLINARY BREAST ONCOLOGY GROUP (KMBOG) 1015 (UMIN000004839)

✍ Scribed by Yamamura, Jun; Masuda, Norikazu; Yamamoto, Daigo; Tsuyuki, Shigeru; Yamaguchi, Masahide; Tanaka, Satoru; Tsurutani, Junji; Tokunaga, Sinya; Yoshidome, Katsuhide; Mizutani, Makiko; Aono, Toyokazu; Ooe, Asako; Tanino, Hirokazu; Matsunami, Nobuki; Yasojima, Hiroyuki; Nakayama, Takahiro; Nishida, Yukihiro

Book ID: 122906758
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 52 KB
Volume: 22
Category: Article
ISSN: 0960-9776
DOI: 10.1016/S0960-9776(13)70069-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

455 A phase II study of first-line combi

455 A phase II study of first-line combination chemotherapy with docetaxel and gemcitabine in anthracycline-pretreated, Her-2 negative metastatic breast cancer (MBC)

✍ F. Lenz; F. Beldermann; M. Geberth; G. Bastert; A. Schneeweiss 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Phase II Study of Gemcitabine and Bevaci

Phase II Study of Gemcitabine and Bevacizumab As First-Line Treatment in Taxane-Pretreated, HER2-Negative, Locally Recurrent or Metastatic Breast Cancer

✍ Rachel Borson; Graydon Harker; James Reeves; Thaddeus Beck; Steven Hager; Willia 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 387 KB

The Combination of Gemcitabine and Vinor

The Combination of Gemcitabine and Vinorelbine is an Active Regimen as Second-Line Therapy in Patients with Metastatic Breast Cancer Pretreated with Taxanes and/or Anthracyclines: a Phase I–II Study

✍ Alessandro Morabito; Gianfranco Filippelli; Sergio Palmeri; Stefano Cascinu; Fra 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 90 KB

Phase II study of lapatinib in combinati

Phase II study of lapatinib in combination with vinorelbine in patients with HER2 positive recurrent or metastatic breast cancer: A multicentric Turkish Oncology Group (TOG) trial

✍ Saip, P.; Eralp, Y.; Sen, F.; Karaca, H.; Ozkan, M.; Cetin, B.; Benekli, M.; Kuc 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 232 KB

470 Final results of a phase II study of

470 Final results of a phase II study of combination with nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy in patients with HER2-negative metastatic breast cancer

✍ S. Glück; C. Lobo; G. Lopes; A. Castrellon; J. Hurley; I. Reis; S. Richman; O. S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Pegylated liposomal doxorubicin in combi

Pegylated liposomal doxorubicin in combination with vinorelbine as salvage treatment in pretreated patients with advanced breast cancer: a multicentre phase II study

✍ Alexandros Ardavanis; Dimitris Mavroudis; Kostas Kalbakis; Nikolaos Malamos; Kos 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 292 KB